SCHEMBL7308312

SCHEMBL7308312

COc1ccc(SC(CC2CCCC2)C(C(=O)NOC(C)(C)C)C(C)C)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.41
EPHX2 P34913 2/20 0.38
KLK7 P49862 3/20 0.38
MMP3 P08254 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
MDM2 Q00987 1/20 0.38
MMP1 P03956 1/20 0.37
MMP9 P14780 1/20 0.37
MMP13 P45452 1/20 0.37
ADAM17 P78536 1/20 0.37
CHRM2 P08172 1/20 0.36
CPB2 Q96IY4 1/20 0.36
PPARA Q07869 1/20 0.36
CTSK P43235 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7307517 0.87 ADAM17 (0.43) ALDH1A1EPHX2KLK7MMP3MEN1
SCHEMBL7302605 0.84 ALDH1A1 (0.41) ALDH1A1EPHX2KLK7NPC1RAB9A
SCHEMBL7309436 0.79 MMP1 (0.50) ALDH1A1KLK7MMP3KMT2AMMP1
SCHEMBL7310255 0.78 EPHX2 (0.43) ALDH1A1EPHX2KLK7MMP3SMN1; SMN2
SCHEMBL27461841 0.78 ALDH1A1 (0.42) ALDH1A1EPHX2MMP3SMN1; SMN2NPC1
SCHEMBL7311621 0.77 ALDH1A1 (0.44) ALDH1A1KLK7SMN1; SMN2NPC1RAB9A
SCHEMBL7312224 0.76 ADAM17 (0.48) ALDH1A1MMP3SMN1; SMN2NPC1RAB9A
SCHEMBL7304794 0.69 EPHX2 (0.43) ALDH1A1EPHX2KLK7MMP3NPC1
SCHEMBL7308194 0.68 MMP3 (0.53) ALDH1A1EPHX2KLK7MMP3NPC1
SCHEMBL7311450 0.67 MMP3 (0.63) ALDH1A1EPHX2MMP3KMT2AMMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0780386-B1 Matrix metalloprotease inhibitors HOFFMANN LA ROCHE (CH) 2002-10-02 EP disclosed
US-5932595-A ANTIARTHRITIC AGENT; MULTIPLE SCLEROSIS; OSTEOPOROSIS; RESPIRATORY SYSTEM DISORDERS; SKIN DISORDERS; ANTIULCER AGENT SYNTEX (U.S.A.) INC. (US) 1999-08-03 US disclosed
EP-0780386-A1 Matrix metalloprotease inhibitors F. HOFFMANN-LA ROCHE AG (CH) 1997-06-25 EP disclosed